New Share Buyback Programme

Summary by AI BETAClose X

B.P. Marsh & Partners Plc has launched a new share buy-back programme with an irrevocable commitment to Singer Capital Markets for up to £2 million, following the completion of a prior programme where 291,583 ordinary shares were repurchased for £2 million. The new programme will repurchase shares on the open market, with a maximum price limit, and the repurchased shares will be held in treasury. This initiative operates under a general authority granted by shareholders to purchase up to 3,710,000 ordinary shares, with the authority expiring at the 2026 AGM, and the company intends to seek renewal. The primary purpose of the programme is to reduce the company's share capital.

Disclaimer*

B.P. Marsh & Partners PLC
26 March 2026
 

26 March 2026

 

B.P. Marsh & Partners Plc

("B.P. Marsh", the "Company" or the "Group")

 

New Share Buyback Programme

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early stage financial services businesses, today announces the launch of a new share buy-back programme (the "Programme"). This follows completion of the buyback programme announced on 17 April 2025 pursuant to which 291,583 Ordinary Shares were repurchased for a total consideration of £2 million.

 

The Company has entered into an irrevocable commitment with Singer Capital Markets to manage the Programme through a non-discretionary programme, repurchasing the Company's Ordinary Shares on its behalf, for up to a maximum aggregate consideration of £2 million, and within certain defined parameters. Singer Capital Markets will make trading decisions in relation to the buyback of Ordinary Shares independently of the Company within the programme terms and will therefore have the ability to trade during close periods.

 

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms. The maximum price paid per Ordinary Share will be no more than the higher of (a) 5 per cent. above the average middle market quotations for an Ordinary Share (as derived from the AIM Appendix to the London Stock Exchange Daily Official List) for the five business days immediately prior to the day the purchase is made and (b) the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out. Under the Programme, the repurchased shares will be held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Programme will operate in accordance with the Company's general authority to purchase a maximum of 3,710,000 Ordinary Shares (the "Authority"), granted by its shareholders at the General Meeting of the Company held on 2 June 2025 (since when the Company repurchased 1,060,814 Ordinary Shares pursuant to the Authority, comprising 291,583 Ordinary Shares as referred to above and separately a further 769,231 Ordinary Shares as announced on 7 August 2025).

 

Unless renewed sooner, the Authority will expire at the Company's next Annual General Meeting (the "2026 AGM") or, if earlier, at the close of business on 31 July 2026. The Company expects to seek shareholders' approval authorising another such general authority for a further approximate twelve months in due course at the 2026 AGM in accordance with the parameters set out above.

 

The purpose of the Programme is to reduce the Company's share capital. The Company confirms that it currently has no unpublished price sensitive information.

 

The Company will make further regulatory announcements in respect of repurchases of Ordinary Shares as required by the UK's version of the Market Abuse Regulation and the AIM Rules for Companies.

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact:

 

B.P. Marsh & Partners Plc

Daniel Topping / Alice Foulk

 

Tel: +44 (0) 20 7233 3112

 

Nominated Adviser & Joint Corporate Broker:

 

Singer Capital Markets Advisory LLP

Tel: +44 (0) 20 7496 3000

Charles Leigh-Pemberton / Peter Steel / James Todd

 


Joint Corporate Broker:

Investec Bank plc

Christopher Baird / David Anderson / Maria Gomez de Olea

 

Tel: +44 (0) 20 7597 5970

Financial PR & Investor Relations:


Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

Tel: +44 (0) 20 7920 3150

bpmarsh@tavistock.co.uk

 

About B.P. Marsh

 

B.P. Marsh & Partners Plc (AIM: BPM) is a specialist investor in early stage and small to medium-sized financial services intermediary businesses, with a particular focus on the insurance sector. Bridging the gap to traditional private equity funding rounds, B.P. Marsh takes a typical initial equity stake of up to £5m, often complemented by loans, and is able to tailor its investment model to each opportunity. Taking a long-term view of its investments, with an average holding period of around seven years, the Group supplies strategic insight and capital while empowering entrepreneurial management teams to grow their businesses.

 

The B.P. Marsh portfolio is diversified by geography and class of business, spanning insurance brokers, underwriting agencies and financial advisers in the UK, Europe, North America and other international markets. For further information, including details of the current portfolio and recent exits, please visit: www.bpmarsh.co.uk.

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings